Cited by 320Cystic Fibrosis Research AdvancesBacterial biofilms and quorum sensingGut microbiota and health

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Lung Microbiota and Bacterial Abundance in Patients with Bronchiectasis when Clinically Stable and during Exacerbation

Open access

Tunney, Michael M., Einarsson, Gisli G., Wei, Lan, Drain, Maire, Klem, Erich R., Cardwell, Chris, Ennis, Madeleine, Boucher, Richard C., Wolfgang, Matthew C., Elborn, J. Stuart·2013·American Journal of Respiratory and Critical Care Medicine

DOI 10.1164/rccm.201210-1937ocPMC PMC3734618

Open this paper in CoChat — free account

Abstract

RATIONALE: Characterization of bacterial populations in infectious respiratory diseases will provide improved understanding of the relationship between the lung microbiota, disease pathogenesis, and treatment outcomes. OBJECTIVES: To comprehensively define lung microbiota composition during stable disease and exacerbation in patients with bronchiectasis. METHODS: Sputum was collected from patients when clinically stable and before and after completion of antibiotic treatment of exacerbations. Bacterial abundance and community composition were analyzed using anaerobic culture and 16S rDNA pyrosequencing. MEASUREMENTS AND MAIN RESULTS: In clinically stable patients, aerobic and anaerobic bacteria were detected in 40 of 40 (100%) and 33 of 40 (83%) sputum samples, respectively. The dominant organisms cultured were Pseudomonas aeruginosa (n = 10 patients), Haemophilus influenzae (n = 12), Prevotella (n = 18), and Veillonella (n = 13). Pyrosequencing generated more than 150,000 sequences, representing 113 distinct microbial taxa; the majority of observed community richness resulted from taxa present in low abundance with similar patterns of phyla distribution in clinically stable patients and patients at the onset of exacerbation. After treatment of exacerbation, there was no change in total (P = 0.925), aerobic (P = 0.917), or anaerobic (P = 0.683) load and only a limited shift in community composition. Agreement for detection of bacteria by culture and pyrosequencing was good for aerobic bacteria such as P. aeruginosa (κ = 0.84) but poorer for other genera including anaerobes. Lack of agreement was largely due to bacteria being detected by pyrosequencing but not by culture. CONCLUSIONS: A complex microbiota is present in the lungs of patients with bronchiectasis and remains stable through treatment of exacerbations, suggesting that changes in microbiota composition do not account for exacerbations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1164/rccm.201210-1937oc

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,806
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F. S. F., Utokaparch, S., Woods, R. R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,828
Disordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C. M., Pedro, H., Cárdenas, P., Bush, A., Bossley, C. J., Davies, J. C., Ervine, A., Poulter, L. W., Pachter, L. S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,874
Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
Fuchs, H. J., Borowitz, D., Christiansen, D. H., Morris, E. M., Nash, M. L., Ramsey, B. W., Rosenstein, B. J., Smith, A. L., & Wohl, M. E. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409083311003 · Cited by 1,532
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., PEPE, M. S., Quan, J. M., Otto, K., Montgomery, A. B., Williams‐Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,296
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
Sethi, S., & Murphy, T. F. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800353 · Cited by 1,238
Topographical Continuity of Bacterial Populations in the Healthy Human Respiratory Tract
Charlson, E. S., Bittinger, K., Haas, A. R., Fitzgerald, A. S., Frank, I., Yadav, A., Bushman, F. D., & Collman, R. G. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0655oc · Cited by 1,144
British Thoracic Society guideline for non-CFbronchiectasis
Pasteur, M. C., Bilton, D., Hill, A. T., & on behalf of the British Thoracic Society Bronchiectasis (non-CF) Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136119 · Cited by 1,043
Analysis of the lung microbiome in the “healthy” smoker and in COPD.
Erb-Downward, J. R., Thompson, D. L., Han, M. K., Freeman, C. M., McCloskey, L., Schmidt, L. A., Young, V. B., Toews, G. B., Curtis, J. L., Sundaram, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016384 · Cited by 973 · cited 6×
“For example, genomic differences have been shown to be associated with the ability of H. influenzae strains to cause exacerbations of COPD (51).”
BackgroundResultInfluential
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Kanoh, S., & Rubin, B. K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00078-09 · Cited by 722

Flagged first, then by citations

Show all 62 references

Research works printed but not linked: 1

Einarsson, 2011, Microbial community composition in the lungs of patients with cystic fibrosis and non-CF bronchiectasis [abstract], Thorax, 66, A48

Sorted by citations

Items 101–200 of 320

Viruses in bronchiectasis: a pilot study to explore the presence of community acquired respiratory viruses in stable patients and during acute exacerbations
Mitchell, A. B., Mourad, B., Buddle, L., Peters, M. J., Oliver, B. G. G., & Morgan, L. C. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0636-2 · Cited by 47
Brazilian consensus on non-cystic fibrosis bronchiectasis
Pereira, M. C., Athanazio, R. A., Dalcin, P. D. T. R., de Figueiredo, M. R. F., Gomes, M., de Freitas, C. G., Lundgren, F. L. C., Paschoal, I. A., Rached, S. Z., & Maurici, R. (2019) · Jornal Brasileiro de Pneumologia · doi:10.1590/1806-3713/e20190122 · Cited by 55
The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health
Thornton, C. S., Mellett, M., Jarand, J. M., Barss, L., Field, S. K., & Fisher, D. A. (2021) · European Respiratory Review · doi:10.1183/16000617.0299-2020 · Cited by 44
Effect of invasive mechanical ventilation on the diversity of the pulmonary microbiota
Liu, C., Wu, K., Sun, T., Chen, B., Yi, Y., Ren, R., Xie, L., & Xiao, K. (2022) · Critical Care · doi:10.1186/s13054-022-04126-6 · Cited by 47
Infection and the microbiome in bronchiectasis
Aogáin, M. M., Dicker, A., Mertsch, P., & Chotirmall, S. H. (2024) · European Respiratory Review · doi:10.1183/16000617.0038-2024 · Cited by 49
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration
Chalmers, J. D., Crichton, M. L., Goeminne, P., Loebinger, M. R., HAWORTH, C. S., Almagro, M., Vendrell, M., Soyza, A. D., Dhar, R., Morgan, L. C., et al. (2017) · Breathe · doi:10.1183/20734735.005117 · Cited by 44
Towards Inhaled Phage Therapy in Western Europe
Wienhold, S.-M., Lienau, J., & Witzenrath, M. (2019) · Viruses · doi:10.3390/v11030295 · Cited by 48
Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases
Chellappan, D. K., Ning, Q. L. S., Min, S. K. S., Bin, S. Y., Pang, J.-C., Shi, T. P., Mei, S. W. E., Yee, T. H., Qi, O. J., Thangavelu, L. P., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108732 · Cited by 44
Inactivation of FOXA2 by Respiratory Bacterial Pathogens and Dysregulation of Pulmonary Mucus Homeostasis
Choi, W., Choe, S., & Lau, G. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00515 · Cited by 43
Bronchiectasis
Barbosa, M. T. R., & Chalmers, J. D. (2023) · La Presse Médicale · doi:10.1016/j.lpm.2023.104174 · Cited by 46
Inflammatory Responses, Spirometry, and Quality of Life in Subjects With Bronchiectasis Exacerbations
Guan, W., Gao, Y., Xu, G., Lin, Z., Tang, Y., Li, H., Lin, Z., Jiang, M. H., Zheng, J.-P., Chen, R., et al. (2015) · Respiratory Care · doi:10.4187/respcare.04004 · Cited by 43
Quantitative assessment of individual populations within polymicrobial biofilms
Lopes, S. P., Azevedo, N. F., & Pereira, M. O. (2018) · Scientific Reports · doi:10.1038/s41598-018-27497-9 · Cited by 42
The Airway Microbiome-IL-17 Axis: a Critical Regulator of Chronic Inflammatory Disease
Mannion, J. M., McLoughlin, R. M., & Lalor, S. J. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08928-y · Cited by 42
Sputum matrix metalloproteinase‐8 and ‐9 and tissue inhibitor of metalloproteinase‐1 in bronchiectasis: Clinical correlates and prognostic implications
Guan, W., Gao, Y., Xu, G., Lin, Z., Tang, Y., Gu, Y., Liu, G., Li, H., Chen, R., & Zhong, N. (2015) · Respirology · doi:10.1111/resp.12582 · Cited by 40
Low IgA Associated With Oropharyngeal Microbiota Changes and Lung Disease in Primary Antibody Deficiency
Berbers, R.-M., Hoesein, F. A. A. M., Ellerbroek, P. M., van Montfrans, J. M., Dalm, V. A. S. H., van Hagen, P. M., Paganelli, F. L., Viveen, M. C., Rogers, M. R. C., de Jong, P. A., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01245 · Cited by 40
How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis
Terranova, L., Oriano, M., Teri, A., Ruggiero, L., Tafuro, C., Marchisio, P., Gramegna, A., Contarini, M., Franceschi, E., Sottotetti, S., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103256 · Cited by 38
Bacterial colonization and associated factors in patients with bronchiectasis
Börekçi, Ş., Halis, A., Aygün, G., & Müsellim, B. (2015) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.172297 · Cited by 38
Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines
Brennan, M., McDonnell, M. J., Harrison, M. J., Duignan, N., O'Regan, A. W., Murphy, D. M., Ward, C., & Rutherford, R. M. (2022) · Respiratory Research · doi:10.1186/s12931-022-01947-5 · Cited by 34
Bronchial Microbiome, PA Biofilm-Forming Capacity and Exacerbation in Severe COPD Patients Colonized by P. Aeruginosa
García-Núñez, M., Martí, S., Puig, C., Pérez‐Brocal, V., Millares, L., Santos, S., Ardanuy, C., Moyá, A., Liñares, J., & Monsó, E. (2017) · Future Microbiology · doi:10.2217/fmb-2016-0127 · Cited by 37
Fungi in Cystic Fibrosis and Non–Cystic Fibrosis Bronchiectasis
Moss, R. B. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1546750 · Cited by 34
Antimicrobial treatment of non-cystic fibrosis bronchiectasis
Grimwood, K., Bell, S. C., & Chang, A. B. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.952282 · Cited by 33
Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients
Sherrard, L. J., Schaible, B., Graham, K., McGrath, S., McIlreavey, L., Hatch, J., Wolfgang, M. C., Muhlebach, M. S., Gilpin, D. F., Schneiders, T., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku192 · Cited by 33
Self-citation
The intestinal microbiota and improving the efficacy of COVID-19 vaccinations
Chen, J., Vitetta, L., Henson, J. D., & Hall, S. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104850 · Cited by 32
Variable ventilation from bench to bedside
Huhle, R., Pelosi, P. P., & de Abreu, M. G. (2016) · Critical Care · doi:10.1186/s13054-016-1216-6 · Cited by 32
Inhaled Drug Therapy 2016: The Year in Review
Dhand, R. (2017) · Respiratory Care · doi:10.4187/respcare.05624 · Cited by 31
Airway surface liquid from smokers promotes bacterial growth and biofilm formation via iron-lactoferrin imbalance
Buonfiglio, L. G. V., Borcherding, J. A., Frommelt, M., Parker, G. J., Duchman, B., Calderón, O. G. V., Fernandez‐Ruiz, R., Noriega, J. E., Stone, E. A., Gerke, A. K., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0743-x · Cited by 33
Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.
Blanchette, C. M., Noone, J., Stone, G. A., Zacherle, E. W., Patel, R., Howden, R., & Mapel, D. W. (2017) · Medical Sciences · doi:10.3390/medsci5040020 · Cited by 32
The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis
Dhand, R. (2017) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2017.1415 · Cited by 31
A clinicians’ review of the respiratory microbiome
Campbell, C. D., Barnett, C. R., & Sulaiman, I. (2022) · Breathe · doi:10.1183/20734735.0161-2021 · Cited by 35
Clinical Aspergillus Signatures in COPD and Bronchiectasis
Tiew, P. Y., Thng, K. X., & Chotirmall, S. H. (2022) · Journal of Fungi · doi:10.3390/jof8050480 · Cited by 33
Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review
Thapa, R., Magar, A. T., Shrestha, J., Panth, N., Idrees, S., Sadaf, T., Bashyal, S., Elwakil, B. H., Sugandhi, V. V., Rojekar, S. V., et al. (2024) · MedComm · doi:10.1002/mco2.70018 · Cited by 33
Microbial diversity within the airway microbiome in chronic pediatric lung diseases
Hahn, A., Warnken, S., Pérez‐Losada, M., Freishtat, R. J., & Crandall, K. A. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.12.006 · Cited by 33
Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know
Maselli, D. J., Amalakuhan, B., Keyt, H., & Díaz, A. A. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.12924 · Cited by 27
Bronchiectasis: Phenotyping a Complex Disease
Chalmers, J. D. (2017) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2017.1286171 · Cited by 27
Bronchodilator response in adults with bronchiectasis: correlation with clinical parameters and prognostic implications.
Guan, W., Gao, Y., Xu, G., Li, H., Yuan, J.-J., Zheng, J.-P., Chen, R., & Zhong, N. (2016) · PubMed Central · doi:10.3978/j.issn.2072-1439.2016.01.05 · Cited by 27
Are Antibiotics Useful for Chronic Rhinosinusitis?
Bachert, C., & Hamilos, D. L. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2015.12.008 · Cited by 27
Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention
Bell, S. C., Elborn, J. S., & Byrnes, C. A. (2018) · Respirology · doi:10.1111/resp.13398 · Cited by 26
Self-citation
Pyocycanin, a Contributory Factor in Haem Acquisition and Virulence Enhancement of Porphyromonas gingivalis in the Lung
Benedyk‐Machaczka, M., Byrne, D. P., Główczyk, I., Potempa, J., Olczak, M., Olczak, T., & Smalley, J. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118319 · Cited by 26
The lung microbiome after lung transplantation
Becker, J. B., Poroyko, V. A., & Bhorade, S. M. (2014) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.890518 · Cited by 27
Challenges in the development of new therapies for bronchiectasis
Chalmers, J. D., Loebinger, M. R., & Aliberti, S. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1019863 · Cited by 25
Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis
Blanco‐Aparicio, M., Canosa, J. L. S., Valiño, P., Egaña, M. M., García, I. V., & Martínez, C. M. (2019) · Chronic Respiratory Disease · doi:10.1177/1479973119872513 · Cited by 25
Exposure to traffic-related air pollution and bacterial diversity in the lower respiratory tract of children
Niemeier‐Walsh, C., Ryan, P., Meller, J., Ollberding, N. J., Adhikari, A., & Reponen, T. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244341 · Cited by 25
Anammox Bacteria Are Potentially Involved in Anaerobic Ammonium Oxidation Coupled to Iron(III) Reduction in the Wastewater Treatment System
Yang, X., Li, H., Su, J., & Zhou, G.-W. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.717249 · Cited by 26
Bronchiectasis in the Last Five Years: New Developments
Khoo, J. K., Venning, V. L., Wong, C., & Jayaram, L. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5120115 · Cited by 23
Capsaicin Cough Sensitivity and the Association with Clinical Parameters in Bronchiectasis
Guan, W., Gao, Y., Xu, G., Lin, Z., Tang, Y., Li, H.-M., Lin, Z., Zheng, J.-P., Chen, R., & Zhong, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113057 · Cited by 22
Bronchiectasis with Chronic Rhinosinusitis is Associated with Eosinophilic Airway Inflammation and is Distinct from Asthma
Shteinberg, M., Chalmers, J. D., Narayana, J. K., Dicker, A., Rahat, M. A., Simanovich, E., Bidgood, L., Cohen, S., Stein, N., Abu-Hilu, N., et al. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202306-551oc · Cited by 21
Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputum
Tunney, M. M., Payne, J., McGrath, S., Einarsson, G. G., Ingram, R. J., Gilpin, D. F., Juarez-Perez, V., & Elborn, J. S. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky357 · Cited by 20
Self-citation
Bacterial flagellin promotes viral entry via an NF-kB and Toll Like Receptor 5 dependent pathway
Benedikz, E. K., Bailey, D., Cook, C. N. L., Gonçalves-Carneiro, D., Buckner, M. M. C., Blair, J. M. A., Wells, T. J., Fletcher, N. F., Goodall, M. D., Flores‐Langarica, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44263-7 · Cited by 22
Altered community compositions of Proteobacteria in adults with bronchiectasis
Guan, W., Yuan, J.-J., Li, H., Gao, Y., Chen, C.-L., Huang, Y., Chen, R., & Zhong, N. (2018) · International Journal of COPD · doi:10.2147/copd.s159335 · Cited by 20
Defining severity in non-cystic fibrosis bronchiectasis
Poppelwell, L., & Chalmers, J. D. (2014) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.896204 · Cited by 20
Is bronchiectasis really a disease?
Shteinberg, M., Flume, P. A., & Chalmers, J. D. (2020) · European Respiratory Review · doi:10.1183/16000617.0051-2019 · Cited by 20
Shared and Specific Lung Microbiota with Metabolic Profiles in Bronchoalveolar Lavage Fluid Between Infectious and Inflammatory Respiratory Diseases
He, Y., Yu, W., Ning, P., Luo, Q., Zhao, L., Xie, Y., Yu, Y., Ma, X., Chen, L., Zheng, Y., et al. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s342462 · Cited by 19
US Patient-Centered Research Priorities and Roadmap for Bronchiectasis
Henkle, E. M., Aksamit, T. R., Daley, C. L., Griffith, D. E., O’Donnell, A. E., Quittner, A. L., Malanga, E., Prieto, D., Leitman, A., & Winthrop, K. L. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.06.032 · Cited by 19
Impact of Radiographic Bronchiectasis in COPD
Shi, L., Wei, F., Tiantian, M., Zhou, W., Li, M., & Wan, Y. (2020) · Respiratory Care · doi:10.4187/respcare.07390 · Cited by 19
Pharmacological Efficacy of Probiotics in Respiratory Viral Infections: A Comprehensive Review
Wahab, S., Almaghaslah, D., Mahmood, S. E., Ahmad, M. F., Alsayegh, A. A., Haddash, Y. M. A., Rahman, M. A., Ahamd, I., Ahmad, W., Khalid, M., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081292 · Cited by 18
Sputum metagenomics in bronchiectasis reveals pan-European variation: an EMBARC-BRIDGE study
Thng, K. X., Tiew, P. Y., Aogáin, M. M., Narayana, J. K., Jaggi, T. K., Ivan, F. X., Shuttleworth, M. K., Long, M. B., Richardson, H., Lind, H., et al. (2025) · European Respiratory Journal · doi:10.1183/13993003.00054-2025 · Cited by 22
The composition of the lung microbiome differs between patients with dermatomyositis and rheumatoid arthritis associated with interstitial lung disease
Lou, Y., Wei, Q., Fan, B., Zhang, L., Wang, X., Chen, Z., Tan, X., & Zheng, Y. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13334 · Cited by 16
Comparison of different conditions for DNA extraction in sputum - a pilot study
Oriano, M., Terranova, L., Teri, A., Sottotetti, S., Ruggiero, L., Tafuro, C., Marchisio, P., Gramegna, A., Amati, F., Nava, F., et al. (2019) · Multidisciplinary Respiratory Medicine · doi:10.1186/s40248-018-0166-z · Cited by 16
Pseudomonas aeruginosa in Bronchiectasis
Fernández‐Barat, L., Alcaraz-Serrano, V., Amaro, R., & Torres, A. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1730921 · Cited by 16
Bronchiectasis: still a problem
Wang, Z. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20132165 · Cited by 15
Chronic lung disease in common variable immune deficiency (CVID): A pathophysiological role for microbial and non-B cell immune factors
Mooney, D., Edgar, D., Einarsson, G. G., Downey, D. G., Elborn, J. S., & Tunney, M. M. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2016.1268568 · Cited by 14
Self-citation
Response of salivary microbiome to temporal, environmental, and surface characteristics under in vitro exposure.
Huang, L.-T., Liang, X., Xiao, G.-C., Du, J., Ye, L.-Y., Su, Q., Liu, C., & Chen, L. (2024) · Forensic Science International: Genetics · doi:10.1016/j.fsigen.2024.103020 · Cited by 12
Pulmonary microbiology and microbiota in adults with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis
Wang, Y., Xiao, J., Yang, X., Liu, Y., Du, J., Bossios, A., Zhang, X., Su, G., Wu, L., Zhang, Z., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03140-w · Cited by 14
A variety of bacterial aetiologies in the lower respiratory tract at patients with endobronchial tuberculosis
Kim, S. B., Lee, W., Lee, J.-H., Lee, S. J., Lee, M. K., Kim, S., Uh, Y., Jung, S., & Shin, B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234558 · Cited by 13
The Open Challenge of in vitro Modeling Complex and Multi-Microbial Communities in Three-Dimensional Niches
Oriano, M., Zorzetto, L., Guagliano, G., Bertoglio, F., van Uden, S., Visai, L., & Petrini, P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.539319 · Cited by 13
Deciphering the microbial landscape of lower respiratory tract infections: insights from metagenomics and machine learning
Li, J., Xiong, A., Wang, J., Wu, X. F., Bai, L., Zhang, L., He, X., & Li, G. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1385562 · Cited by 13
The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract
Glieca, S., Quarta, E., Bottari, B., Lal, V., Sonvico, F., & Buttini, F. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2380334 · Cited by 12
Insights into respiratory microbiome composition and systemic inflammatory biomarkers of bronchiectasis patients
Konovalovas, A., Armalytė, J., Klimkaitė, L., Liveikis, T., Jonaitytė, B., Danila, E., Bironaitė, D., Mieliauskaitė, D., Bagdonas, E., & Aldonytė, R. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.04144-23 · Cited by 12
An overview of major metagenomic studies on human microbiomes in health and disease
Cui, H., Li, Y., & Zhang, X. (2016) · Quantitative Biology · doi:10.1007/s40484-016-0078-x · Cited by 13
Exacerbation of Bronchiectasis
Polverino, E., Rosales-Mayor, E., & Torres, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-61452-6_15 · Cited by 12
Bronchiectasis—Could Immunonutrition Have a Role to Play in Future Management?
Derbyshire, E. J., & Calder, P. C. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.652410 · Cited by 12
Investigation and Management of Bronchiectasis in Nontuberculous Mycobacterial Pulmonary Disease
McShane, P. J. (2023) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2023.07.005 · Cited by 11
Maximal mid-expiratory flow is a surrogate marker of lung clearance index for assessment of adults with bronchiectasis
Guan, W., Yuan, J.-J., Gao, Y., Li, H.-M., Zheng, J.-P., Chen, R., & Zhong, N. (2016) · Scientific Reports · doi:10.1038/srep28467 · Cited by 11
Composition of airway bacterial community correlates with chest HRCT in adults with bronchiectasis
O’Neill, K., Einarsson, G. G., Rowan, S., McIlreavey, L., Lee, A. J., Lawson, J., Lynch, T. B., Horsley, A. R., Bradley, J. M., Elborn, J. S., et al. (2019) · Respirology · doi:10.1111/resp.13653 · Cited by 11
Self-citation
Gender differences in clinical characteristics of patients with non‐cystic fibrosis bronchiectasis in different age groups in northern China
Zhou, Y., Wang, Y., He, S., Wang, W., Wang, X., Li, D., Chen, X., Feng, X., & Bu, X. (2023) · The Clinical Respiratory Journal · doi:10.1111/crj.13596 · Cited by 10
Le microbiome pulmonaire en 2015
Andréjak, C., & Delhaès, L. (2015) · médecine/sciences · doi:10.1051/medsci/20153111011 · Cited by 12
Microbes in Bronchiectasis: The Forest or the Trees?
Harris, J. K., & Zemanick, E. T. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201302-0240ed · Cited by 11
Dynamic Upper and Lower Airway Microbiotas in Paediatric Bronchiectasis Exacerbations: A Pilot Study
Broderick, D. T. J., Regtien, T., Ainsworth, A., Taylor, M. W., & Pillarisetti, N. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.773496 · Cited by 11
New therapies for the prevention and treatment of exacerbations of bronchiectasis
Abo-Leyah, H., & Chalmers, J. D. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000368 · Cited by 10
The past decade in bench research into pulmonary infectious diseases: W hat do clinicians need to know?
Finch, S., Keir, H. R., Dicker, A., & Chalmers, J. D. (2017) · Respirology · doi:10.1111/resp.13106 · Cited by 10
Duration of Antibiotic Therapy in Non-cystic Fibrosis Bronchiectasis
Somayaji, R., & Goss, C. H. (2019) · Current Pulmonology Reports · doi:10.1007/s13665-019-00235-w · Cited by 11
Microbiome profile associated with malignant pleural effusion
Shojaee, S., Sharma, A., Gottel, N., Sanchez, T. M., Gilbert, J. A., & Rahman, N. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232181 · Cited by 11
Respiratory dysbiosis and population-wide temporal dynamics in canine chronic bronchitis and non-inflammatory respiratory disease
Ericsson, A. C., Personett, A. R., Rindt, H., Grobman, M., & Reinero, C. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228085 · Cited by 10
Aerially transmitted human fungal pathogens: What can we learn from metagenomics and comparative genomics?
Aliouat‐Denis, C., Chabé, M., Delhaès, L., & Dei‐Cas, E. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.10.006 · Cited by 10
Nebulized Colistin for Non–Cystic Fibrosis Bronchiectasis: Déjà Vu All Over Again?
Metersky, M. L., & O’Donnell, A. E. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201404-0638ed · Cited by 10
Evidence of persistence of Prevotella spp. in the cystic fibrosis lung
Gilpin, D. F., Nixon, K. A., Bull, M. J., McGrath, S., Sherrard, L. J., Rolain, J., Mahenthiralingam, E., Elborn, J. S., & Tunney, M. M. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000500 · Cited by 9
Self-citation
Validation of the Incremental Shuttle Walk Test as a Clinical End Point in Bronchiectasis
Cartlidge, M. K., Smith, M. P., Bedi, P., Donaldson, S., Clarke, A., Mantoani, L. C., Rabinovich, R., Rossi, A. G., & Hill, A. T. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.09.019 · Cited by 9
Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease
Jaat, F. G., Hasan, S. F., Perry, A., Cookson, S., Murali, S., Perry, J. D., Lanyon, C. V., Soyza, A. D., & Todryk, S. M. (2018) · Respiratory Research · doi:10.1186/s12931-018-0811-2 · Cited by 9
Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders
Scialò, F., Vitale, M., D’Agnano, V., Mariniello, D. F., Perrotta, F., Castaldo, A., Campbell, S. F. M., Pastore, L., Cazzola, M., & Bianco, A. (2023) · Lung · doi:10.1007/s00408-023-00645-3 · Cited by 8
The lung microbiome
Rogers, G. B. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170043 · Cited by 8
Emerging drugs for bronchiectasis: an update
Chang, A. B., Marsh, R. L., Smith‐Vaughan, H., & Hoffman, L. R. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1021683 · Cited by 8
The lung microbiome in children with HIV-bronchiectasis: a cross-sectional pilot study
Masekela, R., Vosloo, S., Venter, S. N., de Beer, Z. W., & Green, R. J. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0632-6 · Cited by 8
Exact variance component tests for longitudinal microbiome studies
Zhai, J., Knox, K. S., Twigg, H. L., Zhou, H., & Zhou, J. J. (2019) · Genetic Epidemiology · doi:10.1002/gepi.22185 · Cited by 8
An Unclassified Microorganism: Novel Pathogen Candidate Lurking in Human Airways
Fukuda, K., Yatera, K., Ogawa, M., Kawanami, T., Yamasaki, K., Noguchi, S., Murphy, R. S., Mukae, H., & Taniguchi, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103646 · Cited by 8
Current and future pharmacotherapy options for non-cystic fibrosis bronchiectasis
Athanazio, R. A., da Costa, J. C., de la Rosa, D., & Martínez‐García, M. Á. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1481392 · Cited by 8
Bronchiectasis Exacerbations: Definitions, Causes, and Acute Management
Perl, S. H., & Shteinberg, M. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1730944 · Cited by 8
Microbiology sampling in non-cystic fibrosis bronchiectasis cases from northern Alberta
Wagner, M. J., Dimitrov, M., Lam, G. Y., Leung, W. M., Tyrrell, G. J., & Vethanayagam, D. P. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288704 · Cited by 7
Long-term antibiotic treatment for non-cystic fibrosis bronchiectasis in adults: evidence, current practice and future use
Goldman, N. R., Loebinger, M., & Wilson, R. (2016) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2016.1258304 · Cited by 7
The Lung Microbiome in Health and Respiratory Diseases
Marimón, J. M. (2018) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000268 · Cited by 7
The mycobiomes and bacteriomes of sputum, saliva, and home dust
Niemeier‐Walsh, C., Ryan, P., Meller, J., Ollberding, N. J., Adhikari, A., Indugula, R., & Reponen, T. A. (2020) · Indoor Air · doi:10.1111/ina.12750 · Cited by 7

Authors: Tunney, M. M., Einarsson, G. G., Wei, L., Drain, M., Klem, E. R., Cardwell, C., Ennis, M., Boucher, R. C., Wolfgang, M. C., & Elborn, J. S.
Affiliations: Cystic Fibrosis and Airways Microbiology Research Group
Centre for Infection and Immunity, School of Medicine, Dentistry, and Biomedical Sciences, Queen’s University Belfast, Belfast, United Kingdom
University of North Carolina at Chapel Hill (US)
Queen's University Belfast (GB)
Corresponding author: Tunney, Michael M.
ORCID: Tunney, Michael M.
Einarsson, Gisli G.
Wei, Lan
Cardwell, Chris
Ennis, Madeleine
Boucher, Richard C.
Wolfgang, Matthew C.
Elborn, J. Stuart
Venue: American Journal of Respiratory and Critical Care Medicine
Publisher: Oxford University Press (OUP)
Published: 2013-05
Volume: 187
Issue: 10
Pages: 1118-1126
ISSN: 1073-449X (ISSN-L)
1535-4970
DOI: 10.1164/rccm.201210-1937oc
PMC: PMC3734618
OpenAlex: W2116345416
Cited by: 316
References: 62
Citations by year: 2026: 9 · 2025: 11 · 2024: 25 · 2023: 21 · 2022: 20 · 2021: 22 · 2020: 18 · 2019: 24 · 2018: 37 · 2017: 35 · 2016: 31 · 2015: 26 · 2014: 31 · 2013: 6
FWCI: 25.52
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: American Journal of Respiratory and Critical Care Medicine (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Research Portal (Queen's University Belfast) (submittedVersion)
Funders: Public Health Agency (STL/3713/07, CDV/3650/07)
National Heart, Lung, and Blood Institute (R01HL092964, HL092964)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: bronchiectasis, lung microbiome, bacterial abundance, exacerbations, sputum microbiome, Pseudomonas aeruginosa, Haemophilus influenzae, Prevotella, Veillonella, anaerobic bacteria, bacterial community composition, antibiotic therapy
MeSH terms: Aged, Anti-Bacterial Agents, Bronchiectasis, Cross-Sectional Studies, Female, Humans, Longitudinal Studies, Lung, Male, Sputum, Cohort Studies, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lung Microbiota and Bacterial Abundance in Patients with Bronchiectasis when Clinically Stable and during Exacerbation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks